Category: News & Comments
Why Celyad’s stock gained $2.30 today
Celyad (CYAD) is an immuno-oncology firm, which created CAR T CELL treatments for cancers, including solid tumors. Celyad announced its consolidated financial results for the six-month period ending 30 June 2018. Celyad’s report is endorsed by Europe. Dr. Christian Homsy, Celyad’s...
Read More
August 23, 2018
0
When all the prophets are taken by surprise
When the Goal is Reaching into the Future, Pessimists Have No Place on the Ship The revolution in the biotech sector has proven to be moving fast towards reaching goals that were impossible to imagine a couple of years ago...
Read More
August 24, 2018
0
Outperforming Biotechs In a Bad Market Day
Outperforming Biotechs On August 27, 2019 we posted “ The Medicines Company Has Agreeable News ” under Today’s Highlights. The Medicines Company We described The Medicines Company ( MDCO ) as a firm focused on cardiovascular diseases with a goal...
Read More
September 3, 2019
0
PTC Therapeutics now with a wealthier pipeline
Before we sell PTC Therapeutics (PTCT) , after the stock had reached and surpassed our latest and highest 2018 target, the firm did the right thing that we expected was good enough to encourage investment in this firm. The good...
Read More
August 28, 2018
0
RegenxBio has good news
We reiterate that undeniably outstanding news about gene therapy is taking time to penetrate investors’ ears. They are still falling victim to bad rules of thumb and critics’ magnifications of the negative impact of some stocks’ dilution when companies with...
Read More
August 30, 2018
0
Moderna Therapeutics: A Big Day Filled with Good News
Moderna Therapeutics Trial Results Moderna Therapeutics ( MRNA ) trial results mark the first systemic mRNA therapeutic to show the production of a secreted protein in humans. Moderna's Product mRNA-1944 successfully encoded for functional antibody ( CHKV-24 ) in humans...
Read More
September 13, 2019
0
Gilead and Galapagos have good news for patients with severely active Ankylosing Spondylitis
Gilead Sciences’ (GILD) and Galapagos’ (GLPG) product filgotinib – a highly selective JAK1 inhibitor has met the primary efficacy endpoint in Phase 2 TORTUGA trial in adults with moderately to severely active ankylosing spondylitis (AS). Patients treated with filgotinib achieved...
Read More
September 7, 2018
0
Amgen and AstraZeneca have in hand a very much needed Asthma drug
In the Week in Review posted yesterday on our website that is experiencing several attempts on its life, we wrote about some firms, including Amgen. In the Amgen’s article we tried to let the reader recognize the importance of Amgen’s...
Read More
September 11, 2018
0
Gilead Sciences: In pursuit of cures for intractable diseases
Gilead Sciences (GILD) has news that we felt good about it for a company that saved millions of lives from the minute, but monster viruses HIV and HCV. Curing millions of patients with HCV, has led Gilead to decide that...
Read More
September 13, 2018
0
CRISPR Therapeutics and Sisters
CRISPR, Intellia and Editas CRISPR Therapeutics ( CRSP ) announced revenues of Q4 2019 that beat analysts’ expectations. Based on the good news the stock market’s technicians contributed to boosting the stock’s price enabling the stock to recuperate a large...
Read More
February 13, 2020
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)